JP2024521765A5 - - Google Patents

Info

Publication number
JP2024521765A5
JP2024521765A5 JP2023572709A JP2023572709A JP2024521765A5 JP 2024521765 A5 JP2024521765 A5 JP 2024521765A5 JP 2023572709 A JP2023572709 A JP 2023572709A JP 2023572709 A JP2023572709 A JP 2023572709A JP 2024521765 A5 JP2024521765 A5 JP 2024521765A5
Authority
JP
Japan
Prior art keywords
formulation
formulation according
phosphodiesterase inhibitor
soluble solvent
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521765A (ja
Filing date
Publication date
Priority claimed from PCT/US2021/034334 external-priority patent/WO2021242913A1/en
Application filed filed Critical
Publication of JP2024521765A publication Critical patent/JP2024521765A/ja
Publication of JP2024521765A5 publication Critical patent/JP2024521765A5/ja
Pending legal-status Critical Current

Links

JP2023572709A 2020-05-26 2021-12-01 勃起不全を治療するための製剤および方法 Pending JP2024521765A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063029881P 2020-05-26 2020-05-26
PCT/US2021/034334 WO2021242913A1 (en) 2020-05-26 2021-05-26 Formulations and methods for treating erectile dysfunction
USPCT/US2021/034334 2021-05-26
PCT/US2021/061488 WO2022250731A1 (en) 2020-05-26 2021-12-01 Formulations and methods for treating erectile dysfunction

Publications (2)

Publication Number Publication Date
JP2024521765A JP2024521765A (ja) 2024-06-04
JP2024521765A5 true JP2024521765A5 (enExample) 2024-12-10

Family

ID=78722740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572709A Pending JP2024521765A (ja) 2020-05-26 2021-12-01 勃起不全を治療するための製剤および方法

Country Status (10)

Country Link
US (1) US20240216383A1 (enExample)
EP (1) EP4157449A4 (enExample)
JP (1) JP2024521765A (enExample)
KR (1) KR20240013128A (enExample)
CN (1) CN116568289A (enExample)
AU (1) AU2021280285A1 (enExample)
BR (1) BR112022024098A2 (enExample)
CA (1) CA3179630A1 (enExample)
IL (1) IL298432A (enExample)
WO (2) WO2021242913A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL247528B1 (pl) * 2023-04-08 2025-07-21 Sativa Med Spolka Akcyjna Płynna kompozycja inhibitorów fosfodiesterazy typu 5 (PDE-5), sposób jej wytwarzania oraz jej zastosowanie do leczenia zaburzeń erekcji

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1237538A2 (en) * 1999-11-18 2002-09-11 Natco Pharma Limited An improved pharmaceutical composition for treating male erectile dysfunction
DE10118306A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
WO2009052421A1 (en) * 2007-10-19 2009-04-23 Innozen, Inc. Composition for administering an active ingredient and method for making and using the same
GB2497933B (en) * 2011-12-21 2014-12-24 Londonpharma Ltd Drug delivery technology
US20140271847A1 (en) * 2013-03-13 2014-09-18 SatisPharma, LLC Formulations and methods for rapid penile erections
US20170014417A1 (en) * 2015-07-14 2017-01-19 Lipp Life Sciences Llc Pharmaceutical administration system for the transdermal application of vardenafil
MX2020005890A (es) * 2017-12-20 2020-10-19 Klaria Pharma Holding Ab Formulacion de pelicula que comprende vardenafil, metodo para su preparacion y uso de la misma.
JP7365409B2 (ja) * 2018-06-28 2023-10-19 エイアールエックス エルエルシー 溶解性単位用量膜構造物を製造するための分配方法

Similar Documents

Publication Publication Date Title
JP2022516895A5 (enExample)
US11388924B2 (en) Nicotine ion pair formulation neutralized with CO2 and process therefor
ES2549224T3 (es) Formulaciones orales de película que comprenden dapoxetina y tadalafilo
JP2022516896A5 (enExample)
JP2022515983A5 (enExample)
JP2024521765A5 (enExample)
ES2605495T3 (es) Solución de atomoxetina
JP2008542237A5 (enExample)
JP6888180B1 (ja) 抗真菌薬を有効成分とする医薬組成物
KR20180002657A (ko) 전신 경화증 (SSc)에 수반되는 수족지 궤양 (DU)의 치료를 위한 sGC 자극제, sGC 활성화제 단독 및 PDE5 억제제와의 조합물의 용도
CN101784257B (zh) 以曲唑酮为基础的稳定的液体药物组合物
AR109093A1 (es) Solución oral que comprende clorhidrato de atomoxetina y sus métodos
CA3127926A1 (en) Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
RU2015134148A (ru) Галеновая форма для введения активного действующего вещества
EP1237538A2 (en) An improved pharmaceutical composition for treating male erectile dysfunction
AR085273A1 (es) Formulacion liquida libre de propelente que comprende una droga antimuscarinica
CN116270464A (zh) 一种克立硼罗气雾剂及其制备方法
JP2013525412A (ja) クルクミンを局所投与するための粘着性の遅効性配合物
EP4370093B1 (en) Aqueous bumetanide-containing liquid
JP2024521765A (ja) 勃起不全を治療するための製剤および方法
US20200330470A1 (en) Film formulation comprising vardenafil, method for its preparation, and use thereof
US12053479B2 (en) Transdermal treatment for erectile dysfunction
RU2021120506A (ru) Жидкая никотиновая композиция
US20140271847A1 (en) Formulations and methods for rapid penile erections
US20110224178A1 (en) Composition and method for treating erectile dysfunction